CCR8-depleting antibodies restore response to radiotherapy plus anti-PD1 therapy in head and neck cancer by targeting intratumoral CCR8+ regulatory T cells
Source Nature 生命科学21h ago
Summary
We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.
Open original- Desk
- Science
- Region
- Global
- Language
- English
- Item ID
- science-09862456
Comments 0 comments
No comments yet. Be the first.